Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 23% ± 7% | |
goblet cell | 4 studies | 22% ± 3% | |
intestinal crypt stem cell | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of PLEK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1327.13 | 653 / 653 | 99% | 87.76 | 599 / 605 |
pancreas | 90% | 238.95 | 294 / 328 | 93% | 118.56 | 166 / 178 |
prostate | 89% | 425.51 | 218 / 245 | 76% | 17.26 | 380 / 502 |
kidney | 99% | 429.52 | 88 / 89 | 65% | 25.37 | 590 / 901 |
stomach | 62% | 399.79 | 223 / 359 | 96% | 98.06 | 274 / 286 |
intestine | 52% | 599.66 | 502 / 966 | 98% | 133.73 | 516 / 527 |
bladder | 43% | 303.05 | 9 / 21 | 89% | 86.00 | 450 / 504 |
skin | 98% | 980.19 | 1764 / 1809 | 34% | 12.84 | 161 / 472 |
esophagus | 39% | 310.66 | 557 / 1445 | 92% | 80.06 | 168 / 183 |
liver | 91% | 756.88 | 205 / 226 | 39% | 17.35 | 158 / 406 |
adrenal gland | 100% | 2665.10 | 258 / 258 | 26% | 19.30 | 60 / 230 |
lung | 25% | 45.15 | 147 / 578 | 83% | 50.07 | 954 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 100% | 109.74 | 45 / 45 |
breast | 23% | 44.15 | 104 / 459 | 66% | 18.21 | 737 / 1118 |
eye | 0% | 0 | 0 / 0 | 86% | 27.76 | 69 / 80 |
uterus | 2% | 10.33 | 4 / 170 | 78% | 76.66 | 357 / 459 |
peripheral blood | 66% | 299.01 | 613 / 929 | 0% | 0 | 0 / 0 |
ovary | 5% | 18.56 | 9 / 180 | 26% | 5.17 | 113 / 430 |
adipose | 6% | 13.28 | 78 / 1204 | 0% | 0 | 0 / 0 |
spleen | 5% | 8.71 | 13 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 10.68 | 69 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.77 | 8 / 2642 | 4% | 0.59 | 25 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 1.21 | 1 / 29 |
heart | 1% | 1.15 | 6 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.27 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0120034 | Biological process | positive regulation of plasma membrane bounded cell projection assembly |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | PLEK2 |
Protein name | Pleckstrin 2 Pleckstrin-2 |
Synonyms | |
Description | FUNCTION: May help orchestrate cytoskeletal arrangement. Contribute to lamellipodia formation. |
Accessions | ENST00000216446.9 ENST00000553387.1 H0YIZ5 ENST00000556532.1 H0YJ64 G3V337 ENST00000555803.5 H0YJD0 Q9NYT0 ENST00000554395.1 |